Merck
CN
Search Within

240-816-6

应用筛选条件
关键词:'240-816-6'
显示 1-1 共 1 条结果 关于 "240-816-6" 范围 论文
Christopher P Regan et al.
The Journal of pharmacology and experimental therapeutics, 324(1), 322-330 (2007-10-31)
Drug discovery efforts have focused recently on atrial-selective targets, including the Kv1.5 channel, which underlies the ultrarapid delayed rectifier current, I(Kur), to develop novel treatments for atrial fibrillation (AF). Two structurally distinct compounds, a triarylethanolamine TAEA and an isoquinolinone 3-[(dimethylamino)-methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one
1/1